Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018.
Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018.
复制标题
DOI:
10.15585/mmwr.mm6946a1
复制
发表时间:
2020-11-20
期刊:
影响因子:
--
通讯作者:
Hall HI
中科院分区:
文献类型:
--
作者:
Bosh KA;Johnson AS;Hernandez AL;Prejean J;Taylor J;Wingard R;Valleroy LA;Hall HI
Life expectancy for persons with human immunodeficiency virus (HIV) infection who receive recommended treatment can approach that of the general population, yet HIV remains among the 10 leading causes of death among certain populations. Using surveillance data, CDC assessed progress toward reducing deaths among persons with diagnosed HIV (PWDH). CDC analyzed National HIV Surveillance System data for persons aged ≥13 years to determine age-adjusted death rates per 1,000 PWDH during 2010–2018. Using the International Classification of Diseases, Tenth Revision, deaths with a nonmissing underlying cause were classified as HIV-related or non–HIV-related. Temporal changes in total deaths during 2010−2018 and deaths by cause during 2010–2017 (2018 excluded because of delays in reporting), by demographic characteristics, transmission category, and U.S. Census region of residence at time of death were calculated. During 2010–2018, rates of death decreased by 36.6% overall (from 19.4 to 12.3 per 1,000 PWDH). During 2010–2017, HIV-related death rates decreased 48.4% (from 9.1 to 4.7), whereas non–HIV-related death rates decreased 8.6% (from 9.3 to 8.5). Rates of HIV-related deaths during 2017 were highest by race/ethnicity among persons of multiple races (7.0) and Black/African American persons (5.6), followed by White persons (3.9) and Hispanic/Latino persons (3.9). The HIV-related death rate was highest in the South (6.0) and lowest in the Northeast (3.2). Early diagnosis, prompt treatment, and maintaining access to high-quality care and treatment have been successful in reducing HIV-related deaths and remain necessary for continuing reductions in HIV-related deaths.
登录
查看更多内容
DOI:
10.15585/mmwr.mm6647e1
发表时间:
2017-12-01
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Dailey AF;Hoots BE;Hall HI;Song R;Hayes D;Fulton P Jr;Prejean J;Hernandez AL;Koenig LJ;Valleroy LA
通讯作者:
Valleroy LA
影响因子:
33.9
作者:
Harris, Norma S.;Johnson, Anna Satcher;Hall, H. Irene
通讯作者:
Hall, H. Irene
DOI:
10.1097/qai.0000000000002398
发表时间:
2020-09-01
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
通讯作者:
--
影响因子:
1.7
作者:
Trepka MJ;Sheehan DM;Fennie KP;Niyonsenga T;Lieb S;Maddox LM
通讯作者:
Maddox LM
影响因子:
3.7
作者:
Samji H;Cescon A;Hogg RS;Modur SP;Althoff KN;Buchacz K;Burchell AN;Cohen M;Gebo KA;Gill MJ;Justice A;Kirk G;Klein MB;Korthuis PT;Martin J;Napravnik S;Rourke SB;Sterling TR;Silverberg MJ;Deeks S;Jacobson LP;Bosch RJ;Kitahata MM;Goedert JJ;Moore R;Gange SJ;North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
通讯作者:
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA